Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
KPLUY Stock Summary
Top 10 Correlated ETFs
KPLUY
In the News
K+S: I See The Bottom, But I'm Cutting My Price Target.
K+S, a fertilizer and salt company, has experienced a decline in earnings due to a contraction in the fertilizer market. The company's annual expected EBITDA is significantly lower than previous years, but sales volumes are expected to remain stable. Despite the current macroeconomic trends, the company is considered a solid investment with potential upside.
K+S Aktiengesellschaft (KPLUY) Q3 2023 Earnings Call Transcript
K+S Aktiengesellschaft (OTCQX:KPLUY) Q3 2023 Earnings Conference Call November 14, 2023 4:00 AM ET Company Participants Julia Bock - Head, IR Burkhard Lohr - CEO Christian Meyer - CFO Conference Call Participants Alexander Jones - Bank of America Christian Faitz - Kepler Chevreux Charlie Bentley - Jefferies Oliver Schwarz - Warburg Konstantin Wiechert - Baader Julia Bock Ladies and gentlemen, welcome to the K+S Third Quarter 2023 Earnings Call. We hope you had a chance to review our posted slides as well as our Q3 documents available on the website.
K+S Aktiengesellschaft (KPLUY) Q2 2023 Earnings Call Transcript
K+S Aktiengesellschaft (OTCQX:KPLUY) Q2 2023 Earnings Conference Call August 10, 2023 4:00 AM ET Company Participants Julia Bock – Head of Investor Relations Burkhard Lohr – Chief Executive Officer Christian Meyer – Chief Financial Officer Conference Call Participants Markus Mayer – Bank of America Thomas Swoboda – Société Générale Christian Faitz – Kepler Andreas Heine – Stifel Alexander Jones – Bank of America Rikin Patel – BNP Exane Lisa De Neve – Morgan Stanley Julia Bock Ladies and gentlemen, welcome to the K+S Second Quarter 2023 Earnings Call. We hope you had a chance to review our posted slides as well as our Q2 documents available on the website.
K+S Aktiengesellschaft: Yet More Upside To Be Had Due To Tightening Spreads
K+S, a leading fertilizer and salt company, has seen strong financial performance with gross margins above 42% and net margins over 25.8%. The company has minor debt and hasn't issued new shares for over 10 years. The company is expected to benefit from global trends such as shrinking arable land and increasing water scarcity, which increase the demand for efficient fertilizers.
Munich Re Shines, Fraport Stagnates, K+S Drops: Reviewing My German Stocks After A Year
It's time to review my investments in three German stocks: Munich Re, Fraport, and K+S. Munich Re performed exceptionally well, Fraport showed average performance, and K+S dropped by 30%. I discuss my expectations for these stocks for the rest of 2023 and beyond.
K+S Aktiengesellschaft (KPLUY) Q1 2023 Earnings Call Transcript
Start Time: 04:00 January 1, 0000 4:26 AM ET K+S Aktiengesellschaft (OTCQX:KPLUY) Q1 2023 Earnings Conference Call May 09, 2023, 04:00 AM ET Company Participants Burkhard Lohr - CEO Christian Meyer - CFO Julia Bock - IR Conference Call Participants Christian Faitz - Kepler Cheuvreux Mubasher Chaudhry - Citi Andreas Heine - Stifel Alexander Jones - Bank of America Michael Schäfer - ODDO Thomas Swoboda - Société Générale Markus Mayer - Baader Julia Bock Ladies and gentlemen, welcome to the K+S First Quarter 2023 Earnings Call. We hope you had a chance to review our posted slides as well as our Q1 documents available on the Web site.
K+S Aktiengesellschaft: After A Drop, There Is Upside To Be Had Here
I've been covering K+S for about a year at this point and would consider my position in the company a long-term one. While macro has changed somewhat since my last piece back in February, the company remains an attractive prospect in the current market.
K+S Aktiengesellschaft (KPLUY) Q4 2022 Earnings Call Transcript
K+S Aktiengesellschaft (OTCQX:KPLUY) Q4 2022 Results Conference Call March 15, 2023 5:00 AM ET Company Participants Julia Bock - Investor Relations Burkhard Lohr - Chief Executive Officer Christian Meyer - Chief Financial Officer Conference Call Participants Markus Mayer - Baader-Helvea Oliver Schwarz - Warburg Research Michael Schaefer - ODDO Julia Bock Ladies and gentlemen, welcome to the analyst conference on full year 2022. We hope you had a chance to review our posted slides as well as the documents available on our website.
K+S Aktiengesellschaft Remains A Good Investment And Play On Fertilizer In 2023
K+S, or Kali & Salz, is a company I've been writing about and investing in for about a year at this point, and have covered it for myself for longer. The current macro means that fertilizer remains at a premium because everything coming out of Russia and Belarus is suspect. K+S has taken advantage and stands to gain.
K+S Has Dropped To Cheap Levels - You Can 'Buy' It Here
The time has come to update my thesis on K+S, a leading European fertilizer company, aside from Yara. However, unlike Yara, K+S focus is on Potash. The small position was of an advantage to me, given that we're down 30% for the year, but the time has come to where the company may be attractive.
KPLUY Financial details
KPLUY Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 10.63 | 6.35 | 8.39 | 14.83 | 20.68 | |
Net income per share | 0.23 | -4.94 | 5.68 | 3.94 | 1.12 | |
Operating cash flow per share | 1.67 | 1.12 | 0.85 | 3.64 | 4.4 | |
Free cash flow per share | 0.35 | -0.28 | -0.08 | 2.4 | 1.82 | |
Cash per share | 1.04 | 0.92 | 1.85 | 2.84 | 2.77 | |
Book value per share | 11.74 | 5.8 | 13.84 | 17.55 | 34.72 | |
Tangible book value per share | 9.13 | 5.59 | 13.63 | 17.08 | 33.84 | |
Share holders equity per share | 11.74 | 5.8 | 13.84 | 17.55 | 34.72 | |
Interest debt per share | 9.26 | 9.29 | 3.48 | 2.14 | 2.43 | |
Market cap | 2.11B | 1.51B | 2.96B | 3.54B | 1.32B | |
Enterprise value | 5.19B | 5B | 4.02B | 4.17B | 1.74B | |
P/E ratio | 23.72 | -0.8 | 1.36 | 2.35 | 6.29 | |
Price to sales ratio | 0.52 | 0.62 | 0.92 | 0.62 | 0.34 | |
POCF ratio | 3.3 | 3.51 | 9.05 | 2.55 | 1.6 | |
PFCF ratio | 15.75 | -13.96 | -93.01 | 3.86 | 3.87 | |
P/B Ratio | 0.47 | 0.68 | 0.56 | 0.53 | 0.2 | |
PTB ratio | 0.47 | 0.68 | 0.56 | 0.53 | 0.2 | |
EV to sales | 1.27 | 2.05 | 1.25 | 0.74 | 0.45 | |
Enterprise value over EBITDA | 7.4 | 15.71 | 1.72 | 1.53 | 2.4 | |
EV to operating cash flow | 8.11 | 11.66 | 12.31 | 3 | 2.12 | |
EV to free cash flow | 38.73 | -46.31 | -126.49 | 4.55 | 5.11 | |
Earnings yield | 0.04 | -1.26 | 0.73 | 0.43 | 0.16 | |
Free cash flow yield | 0.06 | -0.07 | -0.01 | 0.26 | 0.26 | |
Debt to equity | 0.76 | 1.56 | 0.24 | 0.12 | 0.07 | |
Debt to assets | 0.32 | 0.41 | 0.14 | 0.08 | 0.04 | |
Net debt to EBITDA | 4.39 | 10.97 | 0.46 | 0.23 | 0.58 | |
Current ratio | 1.55 | 1.43 | 1.92 | 2.4 | 2.14 | |
Interest coverage | 1.86 | -19.51 | 44.17 | 80.91 | 8.65 | |
Income quality | 2.85 | -0.25 | 0.13 | 0.7 | 3.92 | |
Dividend Yield | 0.02 | 0.01 | 0 | 0.01 | 0.14 | |
Payout ratio | 0.54 | 0 | 0 | 0.03 | 0.91 | |
Sales general and administrative to revenue | 0.01 | 0 | 0 | 0.02 | 0.05 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.09 | 0.01 | 0.01 | 0.02 | 0.02 | |
Capex to operating cash flow | -0.79 | -1.25 | -1.1 | -0.34 | -0.59 | |
Capex to revenue | -0.12 | -0.22 | -0.11 | -0.08 | -0.12 | |
Capex to depreciation | -1.17 | -0.24 | 0.24 | -1.07 | -0.98 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 7.83 | 25.39 | 42.04 | 39.45 | 29.61 | |
ROIC | 0.02 | -0.32 | 0.51 | 0.21 | 0.02 | |
Return on tangible assets | 0.01 | -0.23 | 0.25 | 0.16 | 0.02 | |
Graham Net | -12.23 | -8.78 | -5.28 | -2.25 | -9.18 | |
Working capital | 756.6M | 1.17B | 916M | 1.78B | 1.28B | |
Tangible asset value | 3.5B | 2.14B | 5.22B | 6.54B | 6.34B | |
Net current asset value | -3.96B | -2.25B | -1.53B | -120.9M | -901.9M | |
Invested capital | 0.76 | 1.56 | 0.24 | 0.12 | 0.07 | |
Average receivables | 858.15M | 1.89B | 1.78B | 896.7M | 1.06B | |
Average payables | 240.5M | 214.3M | 187.1M | 249.9M | 324M | |
Average inventory | 740.4M | 636.4M | 490M | 585.8M | 691.55M | |
Days sales outstanding | 74.45 | 442.24 | 69.69 | 75.87 | 88.51 | |
Days payables outstanding | 26.11 | 16.44 | 92.94 | 35.48 | 36.41 | |
Days of inventory on hand | 85.42 | 42.43 | 246.9 | 76.54 | 76.92 | |
Receivables turnover | 4.9 | 0.83 | 5.24 | 4.81 | 4.12 | |
Payables turnover | 13.98 | 22.2 | 3.93 | 10.29 | 10.03 | |
Inventory turnover | 4.27 | 8.6 | 1.48 | 4.77 | 4.74 | |
ROE | 0.02 | -0.85 | 0.41 | 0.22 | 0.03 | |
Capex per share | -1.32 | -1.4 | -0.94 | -1.24 | -2.57 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 3.88 | 3.11 | 2.17 | 2.36 | 5.44 | |
Net income per share | 1.42 | 0.69 | -0.12 | -0.13 | 0.22 | |
Operating cash flow per share | 0.66 | 0.57 | 0.69 | 0.47 | 0.92 | |
Free cash flow per share | 0.28 | 0.29 | 0.42 | 0.18 | 0.02 | |
Cash per share | 2.84 | 2.13 | 1.92 | 2.02 | 2.9 | |
Book value per share | 17.55 | 18.06 | 17.59 | 17.78 | 36.31 | |
Tangible book value per share | 17.08 | 17.55 | 17.18 | 17.36 | 35.39 | |
Share holders equity per share | 17.55 | 18.06 | 17.59 | 17.78 | 36.31 | |
Interest debt per share | 2.09 | 0.91 | 0.83 | 0.84 | 2.61 | |
Market cap | 3.54B | 3.74B | 3.07B | 3.22B | 1.26B | |
Enterprise value | 4.17B | 3.9B | 3.2B | 3.38B | 1.69B | |
P/E ratio | 1.63 | 3.55 | -16.93 | -16.93 | 7.96 | |
Price to sales ratio | 2.39 | 3.14 | 3.71 | 3.66 | 1.3 | |
POCF ratio | 14.13 | 17.2 | 11.66 | 18.28 | 7.7 | |
PFCF ratio | 33.6 | 34.24 | 19.33 | 48.34 | 308.26 | |
P/B Ratio | 0.53 | 0.54 | 0.46 | 0.49 | 0.19 | |
PTB ratio | 0.53 | 0.54 | 0.46 | 0.49 | 0.19 | |
EV to sales | 2.81 | 3.27 | 3.87 | 3.83 | 1.73 | |
Enterprise value over EBITDA | 6.43 | 8.21 | 96.26 | 25.42 | 9.67 | |
EV to operating cash flow | 16.64 | 17.95 | 12.15 | 19.13 | 10.27 | |
EV to free cash flow | 39.56 | 35.72 | 20.14 | 50.6 | 411.26 | |
Earnings yield | 0.15 | 0.07 | -0.01 | -0.01 | 0.03 | |
Free cash flow yield | 0.03 | 0.03 | 0.05 | 0.02 | 0 | |
Debt to equity | 0.12 | 0.05 | 0.05 | 0.05 | 0.07 | |
Debt to assets | 0.08 | 0.03 | 0.03 | 0.03 | 0.04 | |
Net debt to EBITDA | 0.97 | 0.34 | 3.87 | 1.14 | 2.42 | |
Current ratio | 2.4 | 3.6 | 3.46 | 2.3 | 2.14 | |
Interest coverage | 77.13 | 18.63 | -23.83 | 0 | 1.42 | |
Income quality | 0.36 | 0.56 | -4.1 | -2.31 | 4.17 | |
Dividend Yield | 0 | 0 | 0.06 | 0 | 0 | |
Payout ratio | 0 | 0 | -4.23 | 0 | 0 | |
Sales general and administrative to revenue | -0.01 | 0.04 | 0.05 | 0.05 | 0.05 | |
Research and developement to revenue | 0.01 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
Capex to operating cash flow | -0.58 | -0.5 | -0.4 | -0.62 | -0.98 | |
Capex to revenue | -0.1 | -0.09 | -0.13 | -0.12 | -0.16 | |
Capex to depreciation | -1.24 | -1 | -1.02 | -0.95 | -1.35 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 23.71 | 16.72 | 6.86 | 7.14 | 13.46 | |
ROIC | 0.05 | 0.04 | -0.01 | 0 | 0.01 | |
Return on tangible assets | 0.06 | 0.03 | 0 | -0.01 | 0 | |
Graham Net | -2.25 | -1.92 | -2.51 | -2.76 | -9.6 | |
Working capital | 1.78B | 2.08B | 1.79B | 1.36B | 1.28B | |
Tangible asset value | 6.54B | 6.72B | 6.55B | 6.48B | 6.34B | |
Net current asset value | -120.9M | 77.8M | -191.7M | -312.3M | -901.9M | |
Invested capital | 0.12 | 0.05 | 0.05 | 0.05 | 0.07 | |
Average receivables | 1.1B | 1.16B | 998.2M | 801.4M | 847M | |
Average payables | 260.15M | 278.9M | 250.5M | 269.95M | 309.45M | |
Average inventory | 676.3M | 726.6M | 777.05M | 761.65M | 727.65M | |
Days sales outstanding | 71.54 | 86.72 | 92.41 | 77.14 | 86.78 | |
Days payables outstanding | 31.56 | 29.12 | 27.82 | 30.02 | 34.56 | |
Days of inventory on hand | 68.09 | 92.53 | 84.29 | 79.05 | 73.02 | |
Receivables turnover | 1.26 | 1.04 | 0.97 | 1.17 | 1.04 | |
Payables turnover | 2.85 | 3.09 | 3.24 | 3 | 2.6 | |
Inventory turnover | 1.32 | 0.97 | 1.07 | 1.14 | 1.23 | |
ROE | 0.08 | 0.04 | -0.01 | -0.01 | 0.01 | |
Capex per share | -0.38 | -0.28 | -0.27 | -0.29 | -0.89 |
KPLUY Frequently Asked Questions
What is K+S Aktiengesellschaft stock symbol ?
K+S Aktiengesellschaft is a DE stock and trading under the symbol KPLUY
What is K+S Aktiengesellschaft stock quote today ?
K+S Aktiengesellschaft stock price is $7.74 today.
Is K+S Aktiengesellschaft stock public?
Yes, K+S Aktiengesellschaft is a publicly traded company.